ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Synthetic Lethality-based Drugs and Targets Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-28O13137
Home | Market Reports | Science| Biological Sciences
Global Synthetic Lethality based Drugs and Targets Market Research Report 2023
BUY CHAPTERS

Global Synthetic Lethality-based Drugs and Targets Market Insights, Forecast to 2030

Code: QYRE-Auto-28O13137
Report
December 2024
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
AbbVie
Astrazeneca plc
BeiGene Ltd
Clovis Oncology
GlaxoSmithKline PLC
Pfizer Inc
AtlasMedx
Chordia Therapeutics
IDEAYA Biosciences
Mission Therapeutics
Repare Therapeutics
Sierra Oncology
SyntheX Labs

Synthetic Lethality-based Drugs and Targets Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Synthetic Lethality-based Drugs and Targets Market

Synthetic Lethality-based Drugs and Targets Market

In cancers, where mutations have led to the loss of function of one gene, using a drug molecule that specifically targets the corresponding gene of the synlet pair has been demonstrated to be a viable and effective therapeutic regimen. Recent advances in biomarker research, including the development of companion diagnostics, in combination with modern molecular screening platforms, which include clustered regularly interspaced short palindromic repeats (CRISPR)- and RNA interference (RNAi)-based screening techniques, have led to the identification of a number of synthetically lethal gene pairs.
Market Analysis and Insights: Global Synthetic Lethality-based Drugs and Targets Market
The global Synthetic Lethality-based Drugs and Targets market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Synthetic Lethality-based Drugs and Targets market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Synthetic Lethality-based Drugs and Targets, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Synthetic Lethality-based Drugs and Targets, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Synthetic Lethality-based Drugs and Targets revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Synthetic Lethality-based Drugs and Targets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Synthetic Lethality-based Drugs and Targets revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Synthetic Lethality-based Drugs and Targets Market Report

Report Metric Details
Report Name Synthetic Lethality-based Drugs and Targets Market
CAGR 5%
Segment by Type
Segment by Application
  • Medical Research Institution
  • Hospital and Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie, AstraZeneca, BeiGene, Clovis Oncology, GlaxoSmithKline, Pfizer, AtlasMedx, Chordia Therapeutics, IDEAYA Biosciences, Mission Therapeutics, Repare Therapeutics, Sierra Oncology, SyntheX Labs
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Synthetic Lethality-based Drugs and Targets in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Synthetic Lethality-based Drugs and Targets companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Synthetic Lethality-based Drugs and Targets revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Synthetic Lethality-based Drugs and Targets Market report?

Ans: The main players in the Synthetic Lethality-based Drugs and Targets Market are AbbVie, AstraZeneca, BeiGene, Clovis Oncology, GlaxoSmithKline, Pfizer, AtlasMedx, Chordia Therapeutics, IDEAYA Biosciences, Mission Therapeutics, Repare Therapeutics, Sierra Oncology, SyntheX Labs

What are the Application segmentation covered in the Synthetic Lethality-based Drugs and Targets Market report?

Ans: The Applications covered in the Synthetic Lethality-based Drugs and Targets Market report are Medical Research Institution, Hospital and Clinic, Other

What are the Type segmentation covered in the Synthetic Lethality-based Drugs and Targets Market report?

Ans: The Types covered in the Synthetic Lethality-based Drugs and Targets Market report are Monotherapy, Combination Therapy

Recommended Reports

Cancer Therapeutics

Genomics & Diagnostics

Advanced Drug Modalities

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monotherapy
1.2.3 Combination Therapy
1.3 Market by Application
1.3.1 Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Medical Research Institution
1.3.3 Hospital and Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Synthetic Lethality-based Drugs and Targets Market Perspective (2019-2030)
2.2 Global Synthetic Lethality-based Drugs and Targets Growth Trends by Region
2.2.1 Synthetic Lethality-based Drugs and Targets Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Synthetic Lethality-based Drugs and Targets Historic Market Size by Region (2019-2024)
2.2.3 Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Region (2025-2030)
2.3 Synthetic Lethality-based Drugs and Targets Market Dynamics
2.3.1 Synthetic Lethality-based Drugs and Targets Industry Trends
2.3.2 Synthetic Lethality-based Drugs and Targets Market Drivers
2.3.3 Synthetic Lethality-based Drugs and Targets Market Challenges
2.3.4 Synthetic Lethality-based Drugs and Targets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Synthetic Lethality-based Drugs and Targets by Players
3.1.1 Global Synthetic Lethality-based Drugs and Targets Revenue by Players (2019-2024)
3.1.2 Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Players (2019-2024)
3.2 Global Synthetic Lethality-based Drugs and Targets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Synthetic Lethality-based Drugs and Targets, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio
3.4.1 Global Synthetic Lethality-based Drugs and Targets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Synthetic Lethality-based Drugs and Targets Revenue in 2023
3.5 Global Key Players of Synthetic Lethality-based Drugs and Targets Head office and Area Served
3.6 Global Key Players of Synthetic Lethality-based Drugs and Targets, Product and Application
3.7 Global Key Players of Synthetic Lethality-based Drugs and Targets, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Synthetic Lethality-based Drugs and Targets Breakdown Data by Type
4.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Type (2019-2024)
4.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2025-2030)
5 Synthetic Lethality-based Drugs and Targets Breakdown Data by Application
5.1 Global Synthetic Lethality-based Drugs and Targets Historic Market Size by Application (2019-2024)
5.2 Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Synthetic Lethality-based Drugs and Targets Market Size (2019-2030)
6.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type
6.2.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2019-2024)
6.2.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2025-2030)
6.2.3 North America Synthetic Lethality-based Drugs and Targets Market Share by Type (2019-2030)
6.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Application
6.3.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2019-2024)
6.3.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2025-2030)
6.3.3 North America Synthetic Lethality-based Drugs and Targets Market Share by Application (2019-2030)
6.4 North America Synthetic Lethality-based Drugs and Targets Market Size by Country
6.4.1 North America Synthetic Lethality-based Drugs and Targets Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2019-2024)
6.4.3 North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Synthetic Lethality-based Drugs and Targets Market Size (2019-2030)
7.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type
7.2.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2019-2024)
7.2.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2025-2030)
7.2.3 Europe Synthetic Lethality-based Drugs and Targets Market Share by Type (2019-2030)
7.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application
7.3.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2019-2024)
7.3.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2025-2030)
7.3.3 Europe Synthetic Lethality-based Drugs and Targets Market Share by Application (2019-2030)
7.4 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country
7.4.1 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2019-2024)
7.4.3 Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Synthetic Lethality-based Drugs and Targets Market Size (2019-2030)
8.2 China Synthetic Lethality-based Drugs and Targets Market Size by Type
8.2.1 China Synthetic Lethality-based Drugs and Targets Market Size by Type (2019-2024)
8.2.2 China Synthetic Lethality-based Drugs and Targets Market Size by Type (2025-2030)
8.2.3 China Synthetic Lethality-based Drugs and Targets Market Share by Type (2019-2030)
8.3 China Synthetic Lethality-based Drugs and Targets Market Size by Application
8.3.1 China Synthetic Lethality-based Drugs and Targets Market Size by Application (2019-2024)
8.3.2 China Synthetic Lethality-based Drugs and Targets Market Size by Application (2025-2030)
8.3.3 China Synthetic Lethality-based Drugs and Targets Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Synthetic Lethality-based Drugs and Targets Market Size (2019-2030)
9.2 Asia Synthetic Lethality-based Drugs and Targets Market Size by Type
9.2.1 Asia Synthetic Lethality-based Drugs and Targets Market Size by Type (2019-2024)
9.2.2 Asia Synthetic Lethality-based Drugs and Targets Market Size by Type (2025-2030)
9.2.3 Asia Synthetic Lethality-based Drugs and Targets Market Share by Type (2019-2030)
9.3 Asia Synthetic Lethality-based Drugs and Targets Market Size by Application
9.3.1 Asia Synthetic Lethality-based Drugs and Targets Market Size by Application (2019-2024)
9.3.2 Asia Synthetic Lethality-based Drugs and Targets Market Size by Application (2025-2030)
9.3.3 Asia Synthetic Lethality-based Drugs and Targets Market Share by Application (2019-2030)
9.4 Asia Synthetic Lethality-based Drugs and Targets Market Size by Region
9.4.1 Asia Synthetic Lethality-based Drugs and Targets Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Synthetic Lethality-based Drugs and Targets Market Size by Region (2019-2024)
9.4.3 Asia Synthetic Lethality-based Drugs and Targets Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type
10.2.1 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application
10.3.1 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country
10.4.1 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Introduction
11.1.4 AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.1.5 AbbVie Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Introduction
11.2.4 AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.2.5 AstraZeneca Recent Developments
11.3 BeiGene
11.3.1 BeiGene Company Details
11.3.2 BeiGene Business Overview
11.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Introduction
11.3.4 BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.3.5 BeiGene Recent Developments
11.4 Clovis Oncology
11.4.1 Clovis Oncology Company Details
11.4.2 Clovis Oncology Business Overview
11.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Introduction
11.4.4 Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.4.5 Clovis Oncology Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Introduction
11.5.4 GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Introduction
11.6.4 Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.6.5 Pfizer Recent Developments
11.7 AtlasMedx
11.7.1 AtlasMedx Company Details
11.7.2 AtlasMedx Business Overview
11.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Introduction
11.7.4 AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.7.5 AtlasMedx Recent Developments
11.8 Chordia Therapeutics
11.8.1 Chordia Therapeutics Company Details
11.8.2 Chordia Therapeutics Business Overview
11.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.8.4 Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.8.5 Chordia Therapeutics Recent Developments
11.9 IDEAYA Biosciences
11.9.1 IDEAYA Biosciences Company Details
11.9.2 IDEAYA Biosciences Business Overview
11.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Introduction
11.9.4 IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.9.5 IDEAYA Biosciences Recent Developments
11.10 Mission Therapeutics
11.10.1 Mission Therapeutics Company Details
11.10.2 Mission Therapeutics Business Overview
11.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.10.4 Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.10.5 Mission Therapeutics Recent Developments
11.11 Repare Therapeutics
11.11.1 Repare Therapeutics Company Details
11.11.2 Repare Therapeutics Business Overview
11.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Introduction
11.11.4 Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.11.5 Repare Therapeutics Recent Developments
11.12 Sierra Oncology
11.12.1 Sierra Oncology Company Details
11.12.2 Sierra Oncology Business Overview
11.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Introduction
11.12.4 Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.12.5 Sierra Oncology Recent Developments
11.13 SyntheX Labs
11.13.1 SyntheX Labs Company Details
11.13.2 SyntheX Labs Business Overview
11.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Introduction
11.13.4 SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
11.13.5 SyntheX Labs Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
AbbVie
Astrazeneca plc
BeiGene Ltd
Clovis Oncology
GlaxoSmithKline PLC
Pfizer Inc
AtlasMedx
Chordia Therapeutics
IDEAYA Biosciences
Mission Therapeutics
Repare Therapeutics
Sierra Oncology
SyntheX Labs
List of Tables
    Table 1. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Monotherapy
    Table 3. Key Players of Combination Therapy
    Table 4. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Synthetic Lethality-based Drugs and Targets Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Synthetic Lethality-based Drugs and Targets Market Share by Region (2019-2024)
    Table 8. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Synthetic Lethality-based Drugs and Targets Market Share by Region (2025-2030)
    Table 10. Synthetic Lethality-based Drugs and Targets Market Trends
    Table 11. Synthetic Lethality-based Drugs and Targets Market Drivers
    Table 12. Synthetic Lethality-based Drugs and Targets Market Challenges
    Table 13. Synthetic Lethality-based Drugs and Targets Market Restraints
    Table 14. Global Synthetic Lethality-based Drugs and Targets Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Players (2019-2024)
    Table 16. Global Top Synthetic Lethality-based Drugs and Targets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2023)
    Table 17. Global Synthetic Lethality-based Drugs and Targets Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Synthetic Lethality-based Drugs and Targets, Headquarters and Area Served
    Table 20. Global Key Players of Synthetic Lethality-based Drugs and Targets, Product and Application
    Table 21. Global Key Players of Synthetic Lethality-based Drugs and Targets, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Synthetic Lethality-based Drugs and Targets Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2019-2024)
    Table 25. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Synthetic Lethality-based Drugs and Targets Revenue Market Share by Type (2025-2030)
    Table 27. Global Synthetic Lethality-based Drugs and Targets Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Application (2019-2024)
    Table 29. Global Synthetic Lethality-based Drugs and Targets Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Application (2025-2030)
    Table 31. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Synthetic Lethality-based Drugs and Targets Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Synthetic Lethality-based Drugs and Targets Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Synthetic Lethality-based Drugs and Targets Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Synthetic Lethality-based Drugs and Targets Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Synthetic Lethality-based Drugs and Targets Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Synthetic Lethality-based Drugs and Targets Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Synthetic Lethality-based Drugs and Targets Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Synthetic Lethality-based Drugs and Targets Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Synthetic Lethality-based Drugs and Targets Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Synthetic Lethality-based Drugs and Targets Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Synthetic Lethality-based Drugs and Targets Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Synthetic Lethality-based Drugs and Targets Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Synthetic Lethality-based Drugs and Targets Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Synthetic Lethality-based Drugs and Targets Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Synthetic Lethality-based Drugs and Targets Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Synthetic Lethality-based Drugs and Targets Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Synthetic Lethality-based Drugs and Targets Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Synthetic Lethality-based Drugs and Targets Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Synthetic Lethality-based Drugs and Targets Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size by Country (2025-2030) & (US$ Million)
    Table 63. AbbVie Company Details
    Table 64. AbbVie Business Overview
    Table 65. AbbVie Synthetic Lethality-based Drugs and Targets Product
    Table 66. AbbVie Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 67. AbbVie Recent Developments
    Table 68. AstraZeneca Company Details
    Table 69. AstraZeneca Business Overview
    Table 70. AstraZeneca Synthetic Lethality-based Drugs and Targets Product
    Table 71. AstraZeneca Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 72. AstraZeneca Recent Developments
    Table 73. BeiGene Company Details
    Table 74. BeiGene Business Overview
    Table 75. BeiGene Synthetic Lethality-based Drugs and Targets Product
    Table 76. BeiGene Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 77. BeiGene Recent Developments
    Table 78. Clovis Oncology Company Details
    Table 79. Clovis Oncology Business Overview
    Table 80. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product
    Table 81. Clovis Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 82. Clovis Oncology Recent Developments
    Table 83. GlaxoSmithKline Company Details
    Table 84. GlaxoSmithKline Business Overview
    Table 85. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product
    Table 86. GlaxoSmithKline Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 87. GlaxoSmithKline Recent Developments
    Table 88. Pfizer Company Details
    Table 89. Pfizer Business Overview
    Table 90. Pfizer Synthetic Lethality-based Drugs and Targets Product
    Table 91. Pfizer Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 92. Pfizer Recent Developments
    Table 93. AtlasMedx Company Details
    Table 94. AtlasMedx Business Overview
    Table 95. AtlasMedx Synthetic Lethality-based Drugs and Targets Product
    Table 96. AtlasMedx Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 97. AtlasMedx Recent Developments
    Table 98. Chordia Therapeutics Company Details
    Table 99. Chordia Therapeutics Business Overview
    Table 100. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Product
    Table 101. Chordia Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 102. Chordia Therapeutics Recent Developments
    Table 103. IDEAYA Biosciences Company Details
    Table 104. IDEAYA Biosciences Business Overview
    Table 105. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product
    Table 106. IDEAYA Biosciences Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 107. IDEAYA Biosciences Recent Developments
    Table 108. Mission Therapeutics Company Details
    Table 109. Mission Therapeutics Business Overview
    Table 110. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product
    Table 111. Mission Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 112. Mission Therapeutics Recent Developments
    Table 113. Repare Therapeutics Company Details
    Table 114. Repare Therapeutics Business Overview
    Table 115. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product
    Table 116. Repare Therapeutics Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 117. Repare Therapeutics Recent Developments
    Table 118. Sierra Oncology Company Details
    Table 119. Sierra Oncology Business Overview
    Table 120. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product
    Table 121. Sierra Oncology Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 122. Sierra Oncology Recent Developments
    Table 123. SyntheX Labs Company Details
    Table 124. SyntheX Labs Business Overview
    Table 125. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product
    Table 126. SyntheX Labs Revenue in Synthetic Lethality-based Drugs and Targets Business (2019-2024) & (US$ Million)
    Table 127. SyntheX Labs Recent Developments
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Synthetic Lethality-based Drugs and Targets Market Share by Type: 2023 VS 2030
    Figure 3. Monotherapy Features
    Figure 4. Combination Therapy Features
    Figure 5. Global Synthetic Lethality-based Drugs and Targets Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Synthetic Lethality-based Drugs and Targets Market Share by Application: 2023 VS 2030
    Figure 7. Medical Research Institution Case Studies
    Figure 8. Hospital and Clinic Case Studies
    Figure 9. Other Case Studies
    Figure 10. Synthetic Lethality-based Drugs and Targets Report Years Considered
    Figure 11. Global Synthetic Lethality-based Drugs and Targets Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Synthetic Lethality-based Drugs and Targets Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Synthetic Lethality-based Drugs and Targets Market Share by Region: 2023 VS 2030
    Figure 14. Global Synthetic Lethality-based Drugs and Targets Market Share by Players in 2023
    Figure 15. Global Top Synthetic Lethality-based Drugs and Targets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Synthetic Lethality-based Drugs and Targets as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue in 2023
    Figure 17. North America Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Synthetic Lethality-based Drugs and Targets Market Share by Type (2019-2030)
    Figure 19. North America Synthetic Lethality-based Drugs and Targets Market Share by Application (2019-2030)
    Figure 20. North America Synthetic Lethality-based Drugs and Targets Market Share by Country (2019-2030)
    Figure 21. United States Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Synthetic Lethality-based Drugs and Targets Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Synthetic Lethality-based Drugs and Targets Market Share by Type (2019-2030)
    Figure 25. Europe Synthetic Lethality-based Drugs and Targets Market Share by Application (2019-2030)
    Figure 26. Europe Synthetic Lethality-based Drugs and Targets Market Share by Country (2019-2030)
    Figure 27. Germany Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Synthetic Lethality-based Drugs and Targets Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Synthetic Lethality-based Drugs and Targets Market Share by Type (2019-2030)
    Figure 35. China Synthetic Lethality-based Drugs and Targets Market Share by Application (2019-2030)
    Figure 36. Asia Synthetic Lethality-based Drugs and Targets Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Synthetic Lethality-based Drugs and Targets Market Share by Type (2019-2030)
    Figure 38. Asia Synthetic Lethality-based Drugs and Targets Market Share by Application (2019-2030)
    Figure 39. Asia Synthetic Lethality-based Drugs and Targets Market Share by Region (2019-2030)
    Figure 40. Japan Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Synthetic Lethality-based Drugs and Targets Market Share by Country (2019-2030)
    Figure 50. Brazil Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Synthetic Lethality-based Drugs and Targets Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. AbbVie Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 57. AstraZeneca Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 58. BeiGene Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 59. Clovis Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 60. GlaxoSmithKline Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 61. Pfizer Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 62. AtlasMedx Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 63. Chordia Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 64. IDEAYA Biosciences Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 65. Mission Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 66. Repare Therapeutics Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 67. Sierra Oncology Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 68. SyntheX Labs Revenue Growth Rate in Synthetic Lethality-based Drugs and Targets Business (2019-2024)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Synthetic Small Molecules Market Insights Forecast to 2030
Targeting DNA Repair Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Antitumor Drugs Market Research Report 2025
Global CRISPR Gene Testing and Diagnostics Market Research Report 2024
Global CRISPR Gene Detection and Diagnostic Market Research Report 2024
Global RNA Interference RNAi Based Therapeutics Market Research Report 2024
Precision Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CRISPR Based Therapeutics Market Research Report 2024
Global Gene Therapies for Tumor Treatment Market Insights Forecast to 2030
Global Small Molecule Targeted Anti cancer Drug Market Insights Forecast to 2030
Antineoplastic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
DNA Damage Response Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Drugs for Multiple Cancers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
DNA Sequencing In Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Targeted Drugs for NSCLC Market Research Report 2024
Targeted Drugs for Colorectal Cancer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Personalizing Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Computational Drug Discovery Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Genome Based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ovarian Cancer Diagnostics and Therapeutics Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions